| Literature DB >> 24909601 |
Kanokwan Srirattana1, Mariena Ketudat-Cairns, Takashi Nagai, Masahiro Kaneda, Rangsun Parnpai.
Abstract
Trichostatin A (TSA), a histone deacetylase inhibitor, has been widely used to improve the cloning efficiency in several species. This brings our attention to investigation of the effects of TSA on developmental potential of swamp buffalo cloned embryos. Swamp buffalo cloned embryos were produced by electrical pulse fusion of male swamp buffalo fibroblasts with swamp buffalo enucleated oocytes. After fusion, reconstructed oocytes were treated with 0, 25 or 50 nM TSA for 10 h. The results showed that there was no significant difference in the rates of fusion (82-85%), cleavage (79-84%) and development to the 8-cell stage (59-65%) among treatment groups. The highest developmental rates to the morula and blastocyst stages of embryos were found in the 25 nM TSA-treated group (42.7 and 30.1%, respectively). We also analyzed the DNA methylation level in the satellite I region of donor cells and in in vitro fertilized (IVF) and cloned embryos using the bisulfite DNA sequencing method. The results indicated that the DNA methylation levels in cloned embryos were significantly higher than those of IVF embryos but approximately similar to those of donor cells. Moreover, there was no significant difference in the methylation level among TSA-treated and untreated cloned embryos. Thus, TSA treatments at 25 nM for 10 h could enhance the in vitro developmental potential of swamp buffalo cloned embryos, but no beneficial effect on the DNA methylation level was observed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24909601 PMCID: PMC4219989 DOI: 10.1262/jrd.2013-116
Source DB: PubMed Journal: J Reprod Dev ISSN: 0916-8818 Impact factor: 2.214
In vitro development of swamp buffalo cloned embryos after TSA treatment for 10 h
| Treatment | No. of | Fused (%) | Cultured | Cleaved (%) | No. (%)* embryos developed to | ||
| 8-cells | Morula | Blastocyst | |||||
| 0 nM | 11 | 120/140 | 120 | 96 | 60 | 33 | 22 |
| (85.1 ± 6.4) | (81.9 ±13.2) | (62.9 ± 15.0) | (34.8 ± 8.1)b | (23.4 ± 6.0)b | |||
| 25 nM | 12 | 117/143 | 117 | 91 | 58 | 38 | 26 |
| (81.6 ± 5.3) | (78.6 ± 19.1) | (65.4 ± 13.9) | (42.7 ± 9.6)a | (30.1 ± 8.1)a | |||
| 50 nM | 10 | 121/146 | 118 | 96 | 57 | 33 | 25 |
| (82.9 ± 2.2) | (84.1 ± 11.8) | (59.2 ± 11.4) | (37.8 ± 4.6)b | (25.4 ± 4.0)ab | |||
* Percentages calculated from the number of cleaved embryos and that developed to each stage. Values are means ± SD. Different superscripts within a column indicate significant differences (P < 0.05; Duncan’s multiple range test).
Fig. 1.DNA methylation level of the satellite I region in buffalo fibroblasts used as donor cells for somatic cell nuclear transfer. Values are means ± SD.
Fig. 2.DNA methylation level of the satellite I region in IVF and cloned embryos (0, 25 and 50 nM TSA) at the 1-cell, 8-cell and blastocyst stages. Values are means ± SD.